SAMe Treatment Numerous preclinical and clinical studies over the past 2 decades have shown that SAMe is effective in the treatment of psychiatric/neurological diseases, with the consequences of inhibiting progression and improving prognosis of these diseases
It acts on melanocortin receptors in the brain, a different mechanism from PDE5 inhibitors like sildenafil, which work on blood flow
Several studies have reported the synergistic efficacy of ELA combined with non-thermal technologies, such as UV light (Yang et al., 2019) and HHP (Seemeen, 2011)
Improvements in body composition (increased lean mass, reduced fat mass) have been observed in some research models and are cited in preclinical and clinical literature, though robust, large RCT data for aesthetic/bodybuilding uses are limited
GSH is essential for maintaining a healthy immune system